Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biogen (GB:0R1B)
LSE:0R1B
Holding GB:0R1B?
Track your performance easily
See the Price Targets and Ratings of:
0R1B Analyst Ratings
Moderate Buy
16 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0R1B Stock 12 Month Forecast
Average Price Target
$265.60
▲(39.53% Upside)
| Highest Price Target$320.00 | Average Price Target$265.60 | Lowest Price Target$190.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
BMO Capital
Reiterated
10/17/24
Wells Fargo
Reiterated
10/14/24
Morgan Stanley
Reiterated
10/11/24
Raymond James
Initiated
10/10/24
J.P. Morgan
Reiterated
10/08/24
Barclays
Reiterated
10/07/24
RBC Capital
Reiterated
10/04/24
Mizuho Securities
Reiterated
09/30/24
Needham
Reiterated
09/24/24
TD Cowen
$300
Buy
57.60%
Upside
Reiterated
09/24/24
Buy Rating Affirmed for Biogen Amid Surprising Success of Lupus Drug Dapirolizumab Pegol
Robert W. Baird
$294
Buy
54.45%
Upside
Assigned
09/24/24
Baird reiterates Outperform Rating on Biogen (BIIB)Baird analyst Brian Skorney reiterated an Outperform rating and $294.00 price target on Biogen (NASDAQ: BIIB).
Wedbush
$205
Hold
7.70%
Upside
Reiterated
09/22/24
Biogen price target lowered to $205 from $210 at WedbushBiogen price target lowered to $205 from $210 at Wedbush
Oppenheimer
$270
Buy
41.84%
Upside
Reiterated
09/03/24
Oppenheimer Reaffirms Their Buy Rating on Biogen (BIIB)
Canaccord Genuity
$308→$298
Buy
56.55%
Upside
Reiterated
08/06/24
Biogen (BIIB) PT Lowered to $298 at Canaccord GenuityCanaccord Genuity analyst Sumant Kulkarni lowered the price target on Biogen (NASDAQ: BIIB) to $298.00 (from $308.00) while maintaining a Buy rating.
Best Analysts Covering Biogen
Which Analyst Should I Follow If I Want to Buy GB:0R1B and Sell After:
1 Month
xxx
Success Rate
15/31 ratings generated profit
Average Return
+0.81%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 48.39% of your transactions generating a profit, with an average return of +0.81% per trade.
3 Months
xxx
Success Rate
14/27 ratings generated profit
Average Return
+1.48%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 51.85% of your transactions generating a profit, with an average return of +1.48% per trade.
1 Year
Success Rate
11/37 ratings generated profit
Average Return
-3.85%
reiterated a buy rating 3 months ago
Copying Marc Goodman's trades and holding each position for 1 Year would result in 29.73% of your transactions generating a profit, with an average return of -3.85% per trade.
2 Years
xxx
Success Rate
11/41 ratings generated profit
Average Return
-11.48%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 26.83% of your transactions generating a profit, with an average return of -11.48% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0R1B Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Sep 24
Oct 24
Strong Buy
12
2
3
5
5
Buy
35
33
30
29
23
Hold
14
8
8
11
13
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
61
43
41
45
41
Each month's total comprises the sum of three months' worth of ratings.
0R1B Financial Forecast
0R1B Stock Forecast FAQ
What is GB:0R1B’s average 12-month price target, according to analysts?
Based on analyst ratings, Biogen’s 12-month average price target is $265.60.
What is GB:0R1B’s upside potential, based on the analysts’ average price target?
Biogen has 39.53% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Biogen a Buy, Sell or Hold?
Biogen has a consensus rating of Moderate Buy, which is based on 16 buy ratings, 6 hold ratings and 0 sell ratings.
What is Biogen’s share price target?
The average share price target for Biogen is $265.60. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $320.00 ,and the lowest forecast is $190.00. The average share price target represents 39.53% Increase from the current price of $190.35.
The highest analyst share price target is $320.00 ,and the lowest forecast is $190.00. The average share price target represents 39.53% Increase from the current price of $190.35.
What do analysts say about Biogen?
Biogen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.
How can I buy shares of Biogen?
To buy shares of GB:0R1B, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.